UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010825
Receipt number R000012678
Scientific Title Study of evaluation for efficacy and safety of SMART(Symbicort Maintenance and Reliever Therapy) in poorly controlled asthmatics
Date of disclosure of the study information 2013/05/29
Last modified on 2020/12/03 14:48:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of evaluation for efficacy and safety of SMART(Symbicort Maintenance and Reliever Therapy) in poorly controlled asthmatics

Acronym

SMART(Symbicort Maintenance and Reliever Therapy) in poorly controlled asthmatics

Scientific Title

Study of evaluation for efficacy and safety of SMART(Symbicort Maintenance and Reliever Therapy) in poorly controlled asthmatics

Scientific Title:Acronym

SMART(Symbicort Maintenance and Reliever Therapy) in poorly controlled asthmatics

Region

Japan


Condition

Condition

Bronchial asthma

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate efficacy and safety of SMART (Symbicort Maintenance and Reliever Therapy)

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

ACT score

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

SMART(Symbicort Maintenance and Reliever Therapy)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

poorly controlled asthmatics (ACT score<=24)

Key exclusion criteria

contraindications of Symbicort
current smoker
Infections within 2 weeks
Systemic steroid administration within 2 weeks
Pregnant patients

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Kazuto
Middle name
Last name Hirata

Organization

Graduate school of medicine, Osaka City University

Division name

Department of Respiratory medicine

Zip code

545-8585

Address

1-4-3, Asahimachi, Abenoku, Osaka

TEL

06-6645-3916

Email

kokyuki@med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name Kazuhisa
Middle name
Last name Asai

Organization

Graduate school of medicine, Osaka City University

Division name

Department of Respiratory medicine

Zip code

545-8585

Address

1-4-3, Asahimachi, Abenoku, Osaka

TEL

06-6645-3916

Homepage URL


Email

kokyuki@med.osaka-cu.ac.jp


Sponsor or person

Institute

Department of Respiratory medicine, Graduate school of medicine, Osaka City University

Institute

Department

Personal name



Funding Source

Organization

Department of Respiratory medicine, Graduate school of medicine, Osaka City University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

ethics commitee, Osaka City University

Address

1-4-3, asahimachi, Abeno, Osaka JAPAN

Tel

06-6645-3435

Email

rinri@med.osaka-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 01 Month 08 Day

Date of IRB

2013 Year 05 Month 29 Day

Anticipated trial start date

2013 Year 05 Month 29 Day

Last follow-up date

2013 Year 05 Month 29 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 05 Month 29 Day

Last modified on

2020 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012678


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name